Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.17 USD | -0.12% | +8.67% | +26.57% |
04-26 | Daiwa Adjusts Price Target on Boston Scientific to $81 From $73 | MT |
04-26 | Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75 | MT |
Chart calendar Boston Scientific Corporation
Upcoming events on Boston Scientific Corporation
Past events on Boston Scientific Corporation
2024-04-24 08:00 | Q1 2024 Earnings Call |
2024-04-24 06:30 | Q1 2024 Earnings Release |
2024-03-06 09:10 | TD Cowen Health Care Conference |
2024-01-31 08:00 | Q4 2023 Earnings Call |
2024-01-31 06:30 | Q4 2023 Earnings Release |
2024-01-07 | Acquisition of Axonics, Inc by Boston Scientific Corp. Call |
2023-11-14 08:00 | Stifel Healthcare Conference |
2023-10-26 08:00 | Q3 2023 Earnings Call |
2023-10-26 06:30 | Q3 2023 Earnings Release |
2023-09-20 08:30 | Investor Day |
2023-07-27 07:30 | Q2 2023 Earnings Call |
2023-07-27 06:34 | Q2 2023 Earnings Release |
2023-05-31 08:00 | Bernstein Strategic Decisions Conference |
2023-05-04 08:00 | Annual General Meeting |
2023-04-26 08:00 | Q1 2023 Earnings Call |
2023-04-26 06:30 | Q1 2023 Earnings Release |
2023-03-01 08:00 | Citi Healthcare Services Medtech Tools & HCIT Conference |
2023-02-01 08:00 | FY 2022 Earnings Call |
2023-02-01 06:30 | FY 2022 Earnings Release |
2023-01-11 11:15 | JP Morgan Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 10 735 10 752 -0.16% | 9 913 10 029 -1.16% | 11 888 11 872 0.14% | 12 682 12 683 -0.01% | 14 240 14 109 0.93% | 15 979 |
EBITDA Million USD | Released Forecast Spread | 3 111 3 131 -0.64% | 3 040 2 426 25.32% | 4 103 3 451 18.88% | 3 574 3 640 -1.81% | 4 106 4 068 0.94% | 4 618 |
EBIT Million USD | Released Forecast Spread | 2 800 2 815 -0.54% | 1 917 2 038 -5.92% | 3 010 3 012 -0.07% | 3 241 3 288 -1.43% | 3 738 3 711 0.73% | 4 272 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 687 1 232 -44.21% | -138 76,5 -280.39% | 1 076 1 465 -26.53% | 1 141 1 294 -11.85% | 1 985 2 035 -2.45% | 2 589 |
Net income Million USD | Released Forecast Spread | 4 700 1 116 321.17% | -173 16,2 -1167.62% | 985 1 332 -26.05% | 642 887 -27.66% | 1 570 1 528 2.74% | 2 145 |
EPS USD | Released Forecast Spread | 3,33 0,85 293.88% | -0,12 -0,05 -127.19% | 0,69 0,91 -23.96% | 0,45 0,63 -28.53% | 1,07 1,04 2.58% | 1,44 |
Announcement Date | 05/02/20 | 03/02/21 | 02/02/22 | 01/02/23 | 31/01/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3 127 3 111 0.51% | 3 026 2 956 2.36% | 3 244 3 221 0.73% | 3 170 3 136 1.09% | 3 242 3 243 -0.04% | 3 389 3 159 7.29% | 3 599 3 503 2.73% | 3 527 3 477 1.44% | 3 725 3 596 3.57% | 3 856 3 685 4.65% | 4 018 | 3 955 | 4 169 | 4 209 |
EBITDA Million USD | Released Forecast Spread | 1 109 947 17.07% | 1 055 852 23.9% | 898 903 -0.51% | 892 926 -3.67% | 928 966 -3.93% | 947 890 6.44% | 1 052 1 003 4.93% | 1 011 984 2.77% | 1 095 1 043 5.01% | 1 037 | 1 142 | 1 133 | 1 221 | 1 321 |
EBIT Million USD | Released Forecast Spread | 819 821 -0.3% | 781 744 5.02% | 818 805 1.6% | 810 822 -1.45% | 833 879 -5.28% | 865 815 6.17% | 964 920 4.77% | 919 901 1.97% | 990 960 3.1% | 1 012 954 6.09% | 1 071 | 1 053 | 1 140 | 1 123 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 120 424 -71.66% | 156 213 -26.59% | 345 390 -11.46% | 245 374 -34.4% | 396 455 -12.97% | 444 401 10.65% | 426 445 -4.17% | 610 453 34.66% | 505 555 -9.01% | 608 529 14.86% | 769 | 744 | 831 | 685 |
Net income Million USD | Released Forecast Spread | 80,0 387 -79.31% | 97,0 179 -45.66% | 246 324 -24.07% | 174 328 -46.95% | 126 389 -67.57% | 300 334 -10.19% | 261 374 -30.25% | 505 371 36.28% | 504 434 16.02% | 495 441 12.33% | 530 | 516 | 586 | 611 |
EPS USD | Released Forecast Spread | 0,06 0,28 -78.43% | 0,07 0,17 -58% | 0,17 0,24 -29.17% | 0,12 0,24 -50.41% | 0,09 0,27 -66.25% | 0,21 0,23 -8.19% | 0,18 0,28 -35.05% | 0,34 0,25 34.95% | 0,34 0,29 15.37% | 0,33 0,30 11.37% | 0,35 | 0,35 | 0,40 | 0,40 |
Announcement Date | 02/02/22 | 27/04/22 | 27/07/22 | 26/10/22 | 01/02/23 | 26/04/23 | 27/07/23 | 26/10/23 | 31/01/24 | 24/04/24 | - | - | - | - |
2024-04-29 01:00 | PHILIPS NV: Q1 2024 Earnings Release |
2024-04-29 06:00 | REVVITY, INC.: Q1 2024 Earnings Release |
2024-04-30 06:20 | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
2024-04-30 16:05 | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
2024-05-01 | INMODE LTD.: Q1 2024 Earnings Release |
2024-05-02 07:00 | BRUKER CORPORATION: Q1 2024 Earnings Release |
2024-05-02 16:01 | HOLOGIC, INC.: Q2 2024 Earnings Release |
2024-05-02 16:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
2024-05-02 16:05 | ILLUMINA, INC.: Q1 2024 Earnings Release |
2024-05-06 | QUANTERIX CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Boston Scientific Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BSX Stock
- Calendar Boston Scientific Corporation